首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >In vitro susceptibility of environmental Cryptococcus neoformans variety neoformans isolates from Turkey to six antifungal agents, including SCH56592 and voriconazole.
【24h】

In vitro susceptibility of environmental Cryptococcus neoformans variety neoformans isolates from Turkey to six antifungal agents, including SCH56592 and voriconazole.

机译:来自土耳其的新型环境隐球菌变种新形式分离株对六种抗真菌剂(包括SCH56592和伏立康唑)的体外敏感性。

获取原文
获取原文并翻译 | 示例
       

摘要

The in vitro antifungal susceptibility of 27 environmental (pigeon droppings) isolates of Cryptococcus neoformans var. neoformans, isolated from throughout Turkey, to six antifungal agents (amphotericin B, flucytosine, fluconazole, voriconazole, itraconazole, and SCH56592) was studied. Voriconazole, itraconazole, and SCH56592 all showed comparable activity and were more active than the remaining three antifungal agents tested. Overall, SCH56592 was the most active agent (MIC90, 0.015 microg/ml, at both 48 and 72 h), followed by itraconazole (MIC90, 0.03 microg/ml, at both 48 and 72 h) and voriconazole (MIC90, 0.25 microg/ml, at both 48 and 72 h), respectively. Antifungal susceptibility data for environmental isolates may reflect patterns for the clinical isolates recovered from patients from the same geographic area.
机译:27种新隐隐球菌变种的环境(鸽子粪便)分离物的体外抗真菌药性。研究人员研究了从整个土耳其分离出来的六种抗真菌药(氨苄青霉素B,氟胞嘧啶,氟康唑,伏立康唑,伊曲康唑和SCH56592)中的新型甲虫。伏立康唑,伊曲康唑和SCH56592均显示出可比的活性,并且比其余三种测试的抗真菌剂更具活性。总体而言,SCH56592是活性最高的药物(MIC90,在48和72 h均为0.015 microg / ml),其次是伊曲康唑(MIC90,在48和72 h均为0.03 microg / ml)和伏立康唑(MIC90,0.25 microg / ml)。分别在48小时和72小时)。环境分离株的抗真菌药敏性数据可能反映了从同一地区的患者中回收的临床分离株的模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号